Genlantis is focused on the development of protein expression systems within proteomics as well as efficient delivery technologies for both in vitro and in vivo applications.
Genlantis is focused on the development of protein expression systems within proteomics as well as efficient delivery technologies for both in vitro and in vivo applications.
Genlantis offers a comprehensive line of specialty products that include the GenePORTER® transfection products for gene delivery and plasmid DNA, GeneSilencer® reagent useful in the delivery of siRNA for gene suppression in mammalian cells, NeuroFECT™ reagent for optimized transfection of primary neurons, and NeuroPure™ primary neuronal cells.
In addition, the patented Tap Express® and Xi-Clone Instant Enzymeless PCR Cloning technologies offer scientists the ability to design experiments involving hundreds or even thousands of proteins simultaneously at a very reasonable cost. These patented technologies allow the rapid generation of proteins from complex infectious organisms such as malaria, tuberculosis, anthrax, smallpox virus, Chlamydia, helicobacter, and many more.
“Life Science Research Products and Solutions,,
Genlantis is a division of Gene Therapy Systems, Inc and located in San Diego, California.
Registered Trademarks
GenePORTER® reagent
GeneSilencer® reagent
NeuroPORTER® reagent
TAP Express® system
TurboCells® E. coli
BioPORTER® reagent.
Contact Sanbio for more information about the product portfolio and BeNeLux deliveries of Genlantis.